Figure legends

Figure 1: Schematic workflow of the molecular tumor board . Patients are integrated into the molecular tumor board by registration from the treating physicians. Molecular diagnostics are performed on either already existing samples or newly acquired biopsies. Results are discussed in a biweekly interdisciplinary discussion with physicians and scientists. A treatment recommendation/decision is made either for a targeted or generalized therapeutic strategy or more diagnostic follow-up.
Figure 2: Schematic overview of molecular and patho-clinical data integration towards personalized medicine. Proteomics and phosphoproteomics provide complementary biological information to current state-of-the-art molecular diagnostics within the molecular tumor boards. Integration of genomic and proteomic data promotes comprehensive molecular characterizations and paves the way toward personalized medicine and individualized treatment.